Biomat USA

Biomat USA, a subsidiary of Grifols, was established to focus on the collection of protein-rich plasma from donors. The core mission is to save lives by providing essential plasma for therapies that treat patients with immune deficiencies, hemophilia, and other genetic conditions. With over 175 plasma donation centers across the United States, Biomat USA offers a convenient and crucial service to both donors and patients in need of plasma-derived treatments.

Notable affiliated individuals include the leadership team at Grifols, which has a long history in the healthcare sector since its founding in 1950. Key achievements for Biomat USA include expanding its network of donation centers and contributing significantly to the availability of life-saving plasma therapies. The overall impact of Biomat USA is profound, as it plays a critical role in the healthcare system by ensuring a steady supply of plasma for medical treatments, thereby improving and saving countless lives.